Predicting Our Way Out Of A Crisis

These developments can have disastrous unintended downstream consequences and can very easily lead to increasing stigma and under-treating pain. We cannot adequately predict future outcomes, even with genetic testing, and I don’t believe tools like this have significant validity. As noted on MedPage Today, the company which created the test, SOLVD, presented results of a single <a href="http://www.annclinlabsci.org/content/51/4/451.abstract" rel="noopener ugc nofollow" target="_blank">observational study</a> that utilized machine learning as a predictive algorithm to the FDA which <a href="https://www.medpagetoday.com/neurology/opioids/107962" rel="noopener ugc nofollow" target="_blank">demonstrated a sensitivity of 82.76% and a specificity of 79.23% for detecting opioid use disorder</a>. This level of specificity for what should be considered a critical clinical decision instrument would be considered unacceptable by most standards for predicting bad outcomes. <a href="https://tnicholsmd.medium.com/predicting-our-way-out-of-a-crisis-c80a067a5c4b">Visit Now</a>